Botulinum toxin therapy for apraxia of lid opening.
Boghen
Dan
D
Neuro-ophthalmology Section, Centre Hospitalier de l'Université de Montréal (Hôtel-Dieu), Montréal, Québec, Canada. boghend@videotron.ca
Tozlovanu
Viorika
V
Iancu
Andreea
A
Forget
Robert
R
D001072:Apraxias / Q000188:drug therapy*; D001764:Blepharospasm / Q000188:drug therapy; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004576:Electromyography / Q000187:drug effects; D005143:Eyelids / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D009465:Neuromuscular Agents / Q000627:therapeutic use; D009801:Oculomotor Muscles / Q000187:drug effects / Q000503:physiopathology; D012016:Reference Values
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A